Multiple predicted HCC-related targets

The term Multiple predicted HCC-related targets does not refer to a single, specific therapeutic target, molecule, or receptor. Instead, it is a collective descriptor often used in bioinformatics, network pharmacology, and systems biology studies to categorize a group of proteins or genes identified as potential therapeutic vulnerabilities in hepatocellular carcinoma (HCC). HCC is a highly heterogeneous primary liver cancer, and research frequently employs computational modeling to predict sets of targets that may be involved in its pathogenesis or response to treatment. Because this entry represents an aggregate of undefined molecules rather than a distinct biological entity, it lacks a specific molecular classification, canonical sequence, or defined mechanism of action. In a pharmacological context, this term is considered insufficient for drug-target characterization as it does not specify which individual proteins (such as kinases, growth factor receptors, or metabolic enzymes) are being addressed.